AI
AMRI

Atria Investments’s Albany Molecular Research Inc AMRI Stock Holding History

Atria Investments’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,137
Closed -$350K – 845
2017
Q2 		$350K Sell
16,137
-1,533
-9% -$27.8K 0.02% 517
2017
Q1 		$248K Buy
17,670
+1,782
+11% +$29.2K 0.02% 580
2016
Q4 		$298K Buy
+15,888
New +$270K 0.02% 470

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Atria Investments's AMRI Position: Q3 2017 in Review

Atria Investments sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 16,137 shares — an estimated $350K sold.

Atria Investments first reported a position in AMRI in Q4 2016 and held it in 3 quarters. The position peaked at $350K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Atria Investments reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Atria Investments sold 16,137 Albany Molecular Research Inc shares in Q3 2017, an estimated $350K.
  • Atria Investments first reported a position in Albany Molecular Research Inc in Q4 2016 and held it in 3 quarters.
  • Atria Investments's Albany Molecular Research Inc position peaked at $350K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Atria Investments's 13F filing for Q3 2017, filed 12 Oct 2017.